Autres langues Insulet Corporation

Actions

PODD

US45784P1012

Temps réel estimé Cboe BZX Autres places de cotation 19:10:12 26/04/2024			Varia. 5j.	Varia. 1 janv.
167 ^USD	+1,75 %		-0,02 %	-23,40 %

20/03	Les marchés boursiers américains clôturent en hausse mercredi après que la Fed ait maintenu ses taux d'intérêt	MT
20/03	Insulet nomme Ana Maria Chadwick au poste de directeur financier	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024	03/04
US Equity Markets Close Higher Wednesday as Fed Holds Rates Steady	20/03
Insulet Names Ana Maria Chadwick Finance Chief	20/03
Insulet Appoints Ana Maria Chadwick as Chief Financial Officer	20/03
Insulet Corporation Appoints Ana Maria Chadwick as Executive Vice President, and Treasurer, Effective April 22, 2024	20/03
Insulet Corporation Announces Chief Financial Officer Changes	20/03
3M Board Approves Healthcare Unit Spinoff -- Update	08/03
Insulet Says Trial Shows Omnipod 5 Insulin Delivery System Superior to Pump Therapy	08/03
Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy	08/03
Insulet Corporation Presents Positive Results from its First Randomized Controlled Trial Showing Improved Glycemic and Patient-Reported Outcomes in Type 1 Diabetes with the Omnipod 5 Automated Insulin Delivery System (Omnipod 5)	08/03
Insulet to Present Results from First Omnipod 5 Randomized Controlled Trial at the 17th International Conference on Advanced Technologies and Treatments for Diabetes	06/03
Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)	05/03
Insulet Corporation to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17Th International Conference on Advanced Technologies & Treatments for Diabetes	05/03
Stocks in motion: Alphabet drops as Microsoft signs another AI partnership	26/02
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024	23/02
Insulet forecasts weak annual revenue growth; shares drop	22/02
Insulet Q4 Adjusted Earnings, Revenue Increase; Q1, 2024 Revenue Outlook Set	22/02
Insulet: Q4 Earnings Snapshot	22/02
Insulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)	22/02
Earnings Flash (PODD) INSULET CORPORATION Posts Q4 EPS $1.40, vs. Street Est of $0.66	22/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Insulet Corporation

Actions

PODD

US45784P1012

Autres langues

Filtres